eNauka - pregled

Pregled prema Autor Rancati, Francesca

Prikaz rezultata 1 do 1 od 1
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2011Pre-treated CML Patients in chronic phase (CP) not achieving at least a major cytogenetic remission (MCyR) after imatinib high dose (HD) induction (800 mg/day, 6 months) are at high risk of progression after dose reduction - Sub-analyses from the CELSG phPetzer, Andreas L; Fong, Dominic; Lion, Thomas; Dyagil, Irina; Masliak, Zvenyslava; Bogdanovic, Andrija D  ; Griskevicius, Laimonas; Lejniece, Sandra; Goranov, Stefan; Gercheva, Liana;
Stojanovic, Aleksandar; Peytchev, Dontcho; Tzvetkov, Nikolay; Griniute, Rasa; Oucheva, Radka; Grubinger, T; Kwakkelstein, Marthin; Rancati, Francesca; Gastl, Guenther A; Wolf, Dominik;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.